The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy

Abstract

Healthcare expenditures associated with contemporary CRT non-response management are among the highest for any HF patient group. This illustrates an unmet need for interventions to improve HF outcomes and reduce costs among some CRT recipients.